Evotec SE (EVO) Other financing activities (2010 - 2026)
Evotec SE (EVO) posted Other financing activities of $115.9 for Q1 2026, up 1882.86% sequentially from $5.85 in Q3 2025, and down 47.53% YoY from $220.9 in Q1 2025.
Evotec SE (EVO) Other financing activities (2010 - 2026) Analysis & Trends
Evotec SE has reported Other financing activities for 6 years, with the latest figure at $115.9 in Q1 2026.
- Quarterly Other financing activities fell 47.53% year-over-year to $115.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $346.04 (down 44.25% YoY) and the FY2009 annual result came in at $387796.0, changed N/A from the prior year.
- Other financing activities rose to $115.9 in Q1 2026 per EVO's latest filing, from $5.85 in the prior quarter.
- Over five years, Other financing activities peaked at $396.52 in Q1 2024 and troughed at -$1.01 in Q3 2022.
- A 4-year average of $141.5 and a median of $60.87 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2025: Other financing activities slumped 100.17% in 2022, then grew 5.11% in 2025.
- Over 4 years, Other financing activities stood at -$1.01 in 2022, then surged by 420.42% to $3.23 in 2024, then soared by 80.93% to $5.85 in 2025, then surged by 1882.86% to $115.9 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $115.9, $5.85, and $3.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.90 |
| Mar 31, 2026 | 115.90 |
| Sep 30, 2025 | 5.85 |
| Sep 30, 2025 | 5.85 |
| Jun 30, 2025 | 3.40 |
| Jun 30, 2025 | 3.40 |
| Mar 31, 2025 | 220.90 |
| Mar 31, 2025 | 220.90 |
| Jun 30, 2024 | 3.23 |
| Jun 30, 2024 | 3.23 |
| Mar 31, 2024 | 396.52 |
| Mar 31, 2024 | 396.52 |
| Sep 30, 2022 | -1.01 |
| Sep 30, 2022 | -1.01 |
| Mar 31, 2022 | 387.21 |
| Mar 31, 2022 | 387.21 |
| Sep 30, 2021 | 593.18 |
| Sep 30, 2021 | 593.18 |
| Jun 30, 2021 | 56.60 |
| Jun 30, 2021 | 56.60 |